Inspra Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Heart Failure Post MI: In the (EPHESUS) study, the overall incidence of adverse events and the discontinuation rate due to adverse events reported with eplerenone was similar to placebo.
The most frequent adverse event reported in the EPHESUS study was hyperkalemia with an incidence rate of 3.4% for eplerenone, respectively.
Adverse events reported as follows are those with suspected relationship to treatment. Adverse events are listed by body system and absolute frequency. (See Table 2.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

Inspra Adverse Reactions

eplerenone

Manufacturer:

Viatris

Distributor:

Zuellig Pharma